LLY accused of bogus “analysis” of clinical trial data so they could get out of a contract with a small company, after they signed a deal with another company for a drug for the same disease. You’ve probably already heard about it, but this is a pretty good summary, even if it is from Feuerstein’s company.

https://www.fiercebiotech.com/biotech/nektar-...ext-rezpeg